Immunophenotyping and protein profiling of fontan-associated plastic bronchitis airway casts

Annals of the American Thoracic Society

Volumn 10, Issue 2, 2013, Pages 98-107

  Racz, Jennifer ^a   Mane, Gerta ^a   Ford, Michael ^b   Schmidt, Lindsay ^c   Myers, Jeffrey ^c   Standiford, Theodore J ^d   Schumacher, Kurt R ^e   Fifer, Carlen ^e   Russell, Mark W ^e   Stringer, Kathleen A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MS BIOWORKS   (United States)

^c Department of Pathology   (United States)

^d Division of Pulmonary and Critical Care Medicine   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Fibrin; Histones; Inflammation; Proteomics

Indexed keywords

CYTOKINE; HISTONE H4; PROTEIN; PROTEOME;

ARTICLE; B LYMPHOCYTE; BRONCHITIS; CENTRAL VENOUS PRESSURE; CHILD; CIRCULATION; CONFOCAL MICROSCOPY; CONGENITAL HEART DISEASE; CROUPOUS BRONCHITIS; EOSINOPHIL; FEMALE; FLUORESCENCE ANALYSIS; FONTAN PROCEDURE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PATHOGENESIS; PROTEOMICS;

BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHILD; CYTOKINES; FIBRIN; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HISTONES; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; PROTEOMICS;

EID: 84880854669     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201209-080OC     Document Type: Article

References (52)

1. Healy F, Hanna BD, Zinman R. Pulmonary complications of congenital heart disease. Paediatr Respir Rev 2012;13:10-15.
2. Goldberg DJ, Dodds K, Rychik J. Rare problems associated with the Fontan circulation. Cardiol Young 2010;20:113-119.
3. Heath L, Ling S, Racz J, Mane G, Schmidt L, Myers JL, Tsai WC, Caruthers RL, Hirsch JC, Stringer KA. Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator. Pediatr Cardiol 2011;32:1182-1189.
4. Madsen P, Shah SA, Rubin BK. Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 2005;6:292-300.
5. Seear M, Hui H, Magee F, Bohn D, Cutz E. Bronchial casts in children: a proposed classification based on nine cases and a review of the literature. Am J Respir Crit Care Med 1997;155:364-370.
6. Gibb E, Blount R, Lewis N, Nielson D, Church G, Jones K, Ly N. Management of plastic bronchitis with topical tissue-type plasminogen activator. Pediatrics 2012;130:e446-e450.
7. Fredenburg TB, Johnson TR, Cohen MD. The Fontan procedure: anatomy, complications, and manifestations of failure. Radiographics 2011;31:453-463.
8. Languepin J, Scheinmann P, Mahut B, Le Bourgeois M, Jaubert F, Brunelle F, Sidi D, de Blic J. Bronchial casts in children with cardiopathies: the role of pulmonary lymphatic abnormalities. Pediatr Pulmonol 1999;28:329-336.
9. Caruthers RL, Kempa M, Loo A, Gulbransen E, Kelly E, Erickson SR, Hirsch JC, Schumacher KR, Stringer KA. Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis. Pediatr Cardiol 2013;34:256-261.
10. Racz J, Mane G, Ford M, Schmidt L, Schumacher KR, Fifer C, Russell MW, Caruthers RL, Stringer KA. Complementary approaches of proteomics and immunophenotyping provide insight into the pathogenesis of plastic bronchitis [abstract]. Am J Respir Crit Care Med 2012;185:A2489.
11. Paine R III, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, Thannickal VJ, Burnham EL, Brown MB, Hyzy RC. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012;40:90-97.
12. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006;5:2339-2347.
13. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010;137:288-296.
14. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, Leippe M, Kabelitz D, Janssen O. Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J Proteome Res 2011;10:1603-1620.
15. Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol 2005;23:821-852.
16. Olman MA, Simmons WL, Pollman DJ, Loftis AY, Bini A, Miller EJ, Fuller GM, Rivera KE. Polymerization of fibrinogen in murine bleomycininduced lung injury. Am J Physiol 1996;271:L519-L526.
17. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3:1894-1904.
18. Sisson TH, Simon RH. The plasminogen activation system in lung disease. Curr Drug Targets 2007;8:1016-1029.
19. Cederholm A, Frostegard J. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann N Y Acad Sci 2007;1108:96-103.
20. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195.
21. Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 2010;107:12611-12616.
22. Bai F, Asojo OA, Cirillo P, Ciustea M, Ledizet M, Aristoff PA, Leng L, Koski RA, Powell TJ, Bucala R, et al. A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF). J Biol Chem2012; 287:30653-30663.
23. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159:487-494.
24. Herold S, Tabar TS, Janssen H, Hoegner K, Cabanski M, Lewe- Schlosser P, Albrecht J, Driever F, Vadasz I, Seeger W, et al. Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia. Am J Respir Crit Care Med 2011;183:1380-1390.
25. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E, White MR, Dinarello CA, Apte RN. IL-1a and IL-1b recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 2011;187:4835-4843.
26. Cohen I, Rider P, Carmi Y, Braiman A, Dotan S, White MR, Voronov E, Martin MU, Dinarello CA, Apte RN. Differential release of chromatinbound IL-1a discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci USA 2010;107:2574-2579.
27. Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2009;297:L1035-L1041.
28. Bhandary YP, Shetty SK, Marudamuthu AS, Gyetko MR, Idell S, Gharaee-Kermani M, Shetty RS, Starcher BC, Shetty S. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol 2012;302:L463-L473.
29. Pabst R, Tschernig T. Lymphocytes in the lung: an often neglected cell. Numbers, characterization and compartmentalization. Anat Embryol (Berl) 1995;192:293-299.
30. Rajakariar R, Lawrence T, Bystrom J, Hilliard M, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW. Novel biphasic role for lymphocytes revealed during resolving inflammation. Blood 2008;111:4184-4192.
31. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004;3: 401-416.
32. Workalemahu G, Foerster M, Kroegel C, Braun RK. Human gd-T lymphocytes express and synthesize connective tissue growth factor: effect of IL-15 and TGF-β1 and comparison with αβ-T lymphocytes. J Immunol 2003;170:153-157.
33. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005; 31:674-686, discussion 686.
34. Liang J, Jung Y, Tighe RM, Xie T, Liu N, Leonard M, Gunn MD, Jiang D, Noble PW. A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury. Am J Physiol Lung Cell Mol Physiol 2012;302:L933-L940.
35. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med 2009;15:1318-1321.
36. Pemberton AD, Brown JK, Inglis NF. Proteomic identification of interactions between histones and plasma proteins: implications for cytoprotection. Proteomics 2010;10:1484-1493.
37. Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011;118:3708-3714.
38. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012;7:e32366.
39. Hayakawa M, Sawamura A, Gando S, Jesmin S, Naito S, Ieko M. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis. Thromb Res 2012; 130:906-913.
40. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res 2012;129:290-295.
41. Nishiuma T, Sisson TH, Subbotina N, Simon RH. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography. Am J Respir Cell Mol Biol 2004;31:552-558.
42. Hao Z, Guo C, Jiang X, Krueger S, Pietri T, Dufour S, Cone RE, O'Rourke J. New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls. Blood 2006;108:200-202.
43. Levin EG, Stern DM, Nawroth PP, Marlar RA, Fair DS, Fenton JW II, Harker LA. Specificity of the thrombin-induced release of tissue plasminogen activator from cultured human endothelial cells. Thromb Haemost 1986;56:115-119.
44. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 2009;114: 4886-4896.
45. Kppec M, Wegrzynowicz Z, Zajdel M, Sawecka J, Szumiel I. Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin. Thromb Res 1974;5:359-374.
46. Takabayashi T, Kato A, Peters AT, Hulse KE, Suh LA, Carter R, Norton J, Grammer LC, Cho SH, Tan BK. Excessive fibrin deposition in nasal polyps through reduction of tissue plasminogen activator expression. Am J Respir Cell Mol Biol 2013;187:49-57.
47. Adamali H, Armstrong ME, McLaughlin AM, Cooke G, McKone E, Costello CM, Gallagher CG, Leng L, Baugh JA, Fingerle-Rowson G, et al. Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis. Am J Respir Crit Care Med 2012; 186:162-169.
48. Reeves EP, Williamson M, O'Neill SJ, Greally P, McElvaney NG. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 2011;183:1517-1523.
49. Cruikshank WW, Kornfeld H, Center DM. Interleukin-16. J Leukoc Biol 2000;67:757-766.
50. Rand TH, Cruikshank WW, Center DM, Weller PF. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med 1991;173:1521-1528.
51. Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S. Increased expression of IL-16 in inflammatory bowel disease. Gut 2001;48:326-332.
52. Lefrancais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 2012;109:1673-1678. Health and Human Development